All AbMole products are for research use only, cannot be used for human consumption.
Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue used for the treatment of short-bowel syndrome. Teduglutide has similar binding affinity, agonist potency, and agonist efficacy as GLP-2 in assays with the rat GLP-2 receptor. Administration of teduglutide to rats gave a significant increase in small intestine weight and an increase in the height of intestinal villi.
BMC Pulm Med. 2022 Jan 13;22(1):36.
GLP2-GLP2R signal affects the viability and EGFR-TKIs sensitivity of PC9 and HCC827 cells
Teduglutide purchased from AbMole
| Molecular Weight | 3752.08 |
| Formula | C164H252N44O55S |
| CAS Number | 197922-42-2 |
| Solubility (25°C) | DMSO 30 mg/mL |
| Storage | -20°C, sealed, protect from light |
[2] No authors listed. Aust Prescr. Teduglutide for short bowel syndrome
| Related GLP Receptor Products |
|---|
| V-0219 hydrochloride
V-0219 hydrochloride is an orally active, positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R). |
| GLP-1 receptor agonist 14
GLP-1 receptor agonist 14 is a potent agonist of glucagon-like peptide-1 (GLP-1). |
| NM-003
NM-003 is a GLP-2R agonist that can be used in studies related to inflammatory bowel disease. |
| NB-1002
NB-1002 is a GLP-2R agonist that can be used in studies related to short bowel syndrome. |
| MOD-15014
MOD-15014 is a GLP-2R modulator that can be used in studies related to short bowel syndrome. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
